Should I Buy CMPR? CMPR 2026 Analysis

Should You Buy Cimpress PLC (CMPR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Buy

Latest Price

75.640

1 Day change

2.80%

52 Week Range

82.430

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Buy CMPR now: fundamentals/news are improving (raised FY26 outlook) and Wall Street targets were raised to $95–$100, supporting near-term upside.
Trend bias remains bullish (SMA_5 > SMA_20 > SMA_200), and price is sitting just above a key pivot/support zone (~76.8), which is a reasonable “buy now” spot for an impatient buyer.
Main caveat: momentum is softening (MACD histogram negative and worsening), so upside may be choppier; still, the setup favors a push toward 81.9 then 85.1 if the market cooperates.
Positioning/sentiment: hedge funds are buying (+155% QoQ); insiders/congress show no meaningful confirming signal.
Pattern-based projection is modestly positive: ~+2.59% next month (per provided model), aligning with a buy-now swing thesis.

Technical Analysis

Trend: Bullish moving-average stack (SMA_5 > SMA_20 > SMA_200) suggests the broader trend is still up.
Momentum: MACD histogram -0.256 and negatively expanding = short-term downside/weak momentum remains a risk.
RSI (6): ~40.0 = leaning weak but not deeply oversold; room for a bounce without being “stretched.”
Key levels: Pivot 76.777 (price 77.65 slightly above), Resistance 81.904 (R1) then 85.071 (R2); Support 71.651 (S1) then 68.484 (S2).
Practical read: This is a bullish-trend stock going through a momentum cooldown; buying near pivot favors a rebound attempt toward 82–85.

Options Data

Bearish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Open Interest Put/Call = 5.46: very put-heavy OI, often interpreted as cautious/bearish positioning or hedging demand.
Volume Put/Call = 0.0 (puts traded 0; calls traded 3): today’s tape is too thin to treat as strong real-time bearish flow.
Implied vol: 30D IV ~62.8 vs HV ~52.0; IV percentile 80 suggests options are relatively expensive—market expects bigger moves.
Takeaway: Positioning looks defensive (OI), but lack of put volume reduces conviction that traders are actively pressing downside today.

Technical Summary

Sell

Buy

Positive Catalysts

- Q2 FY2026 revenue > $1B with ~11% YoY growth, signaling demand resilience.
- Management raised FY2026 guidance (revenue growth expected 7%–8%) and guided net income ≥ $79M.
- Operational catalyst: deeper collaboration across Vista / National Pen / BuildASign to drive product and marketing synergies.
- Hedge funds buying (buying amount up 155.46% over last quarter) supports a constructive institutional backdrop.
- Analyst momentum: multiple price target raises recently (to $95 and $100).

Neutral/Negative Catalysts

- Profitability pressure: Q2 FY2026 net income -19% YoY and EPS -17% YoY despite revenue growth.
- Gross margin slipped (down ~1.77% YoY), suggesting mix/cost headwinds.
- Short-term technical momentum is weak (MACD negative and worsening), increasing risk of a dip toward 71.7 support if the market sells off.
- Options positioning shows heavy put open interest, a sign of caution/hedging in the market.

Financial Performance

Latest quarter: FY2026 Q2
Revenue: 1,042,202,000 (+10.97% YoY) — strong top-line growth.
Net income: 49,344,000 (-19.18% YoY) — earnings declined despite higher revenue.
EPS: 1.95 (-17.37% YoY) — confirms profit growth lagging.
Gross margin: 46.52 (-1.77% YoY) — modest margin compression.
Bottom line: growth is solid, but the market will want proof that guidance raise translates into improving profitability over coming quarters.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend is clearly positive: Truist reiterated Buy and raised PT $90 → $100 (2026-01-30); Barrington reiterated Outperform and raised PT $83 → $95 (2026-02-02), following an earlier raise $77 → $83 (2025-11-17).
Wall Street pros: raised FY outlook, demand strength in higher-value offerings, Q2 beat, and a long-term EBITDA target (≥$600M by FY28) provide a credible upside narrative.
Wall Street cons: profitability/margins are not yet moving in the right direction YoY, leaving the stock sensitive to any execution slip.
Influential/insider/political activity: insiders are reported neutral; no recent congress trading data provided/available in the last 90 days.

2 Analyst Rating

Wall Street analysts forecast CMPR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CMPR is 86.5 USD with a low forecast of 83 USD and a high forecast of 90 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

0 Hold

0 Sell

Moderate Buy

Current: 73.580

Low

Averages

86.5

High

Current: 73.580

Low

Averages

86.5

High

Barrington

Outperform

maintain

$83 -> $95

AI Analysis

2026-02-02

Reason

Barrington

Price Target

$83 -> $95

AI Analysis

2026-02-02

maintain

Outperform

Reason

Barrington raised the firm's price target on Cimpress to $95 from $83 and keeps an Outperform rating on the shares after the company reported "solid" Q2 results and raised its FY26 guidance. Cimpress reiterated its target for adjusted EBITDA of at least $600M in FY28, the analyst noted.

Truist

Youssef Squali

Buy

maintain

$90 -> $100

2026-01-30

Reason

Truist

Youssef Squali

Price Target

$90 -> $100

2026-01-30

maintain

Buy

Reason

Truist analyst Youssef Squali raised the firm's price target on Cimpress to $100 from $90 and keeps a Buy rating on the shares. The company's Q2 results exceeded expectations, reflecting sustained demand for elevated, higher-value offerings with stabilization in the Y/Y decline in legacy products, the analyst tells investors in a research note.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CMPR

Unlock Now

CMPR Should I Buy

CMPR Should I Buy

Should You Buy Cimpress PLC (CMPR) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch